1.Craniofacial anomalies: Clinical and molecular perspectives.
Annals of the Academy of Medicine, Singapore 2003;32(2):244-251
The first three disorders discussed are abnormalities of bone: too little bone in cleidocranial dysplasia caused by mutations in RUNX2; too much bone in fibrodysplasia ossificans progressiva with overexpression of BMP4; and abnormal bone in McCune-Albright syndrome and fibrous dysplasia caused by mutations in GNAS1. Disorders of the sonic hedgehog signaling network are discussed next, including holoprosencephaly and the nevoid basal cell carcinoma syndrome, the former being caused by sonic hedgehog (SHH) mutations and the latter being caused by patched mutations (PTCH).
Basal Cell Nevus Syndrome
;
genetics
;
Craniofacial Abnormalities
;
genetics
;
Gene Expression Regulation, Developmental
;
Holoprosencephaly
;
genetics
;
Humans
;
Mutation
2.Holoprosencephaly: an antenatally-diagnosed case series and subject review.
Alvin S T LIM ; Tse Hui LIM ; Su Keyau KEE ; Patrick CHIA ; Subramaniam RAMAN ; Elizabeth L P EU ; Jessie Y C LIM ; Sim Leng TIEN
Annals of the Academy of Medicine, Singapore 2008;37(7):594-597
INTRODUCTIONHoloprosencephaly (HPE) is an uncommon congenital failure of forebrain development. Although the aetiology is heterogeneous, chromosomal abnormalities or a monogenic defect are the major causes, accounting for about 40% to 50% of HPE cases. At least 7 genes have been positively implicated, including SHH, ZIC2, SIX3, TGIF, PTCH1, GLI2, and TDGF1.
CLINICAL PICTURETwelve antenatally- and 1 postnatally-diagnosed cases are presented in this study. These comprised 6 amniotic fluid, 3 chorionic villus, 2 fetal blood, 1 peripheral blood, and 1 product of conception.
OUTCOMEThe total chromosome abnormality rate was 92.3%, comprising predominantly trisomy 13 (66.7%). There was 1 case of trisomy 18, and 3 cases of structural abnormalities, including del13q, del18p, and add4q.
CONCLUSIONDespite the poor outcome of an antenatally-diagnosed HPE and the likely decision by parents to opt for a termination of pregnancy, karyotyping and/or genetic studies should be performed to determine if a specific familial genetic or chromosomal abnormality is the cause. At the very least, a detailed chromosome analysis should be carried out on the affected individual. If the result of high resolution karyotyping is normal, Fluorescence in situ hybridisation (FISH) and/or syndrome-specific testing or isolated holoprosencephaly genetic testing may be performed. This information can be useful in making a prognosis and predicting the risk of recurrence.
Adult ; Chromosome Aberrations ; Female ; Holoprosencephaly ; diagnosis ; genetics ; Humans ; Karyotyping ; Pregnancy ; Prenatal Diagnosis ; Trisomy
3.Analysis of a child with holoprosencephaly due to variant of SIX3 gene.
Hong ZENG ; Ziwen XIAO ; Yongzhe XU ; Wen QIAN ; Wei PAN ; Danqing ZHAO
Chinese Journal of Medical Genetics 2021;38(7):656-658
OBJECTIVE:
To explore the genetic basis of a child with holoprosencephaly.
METHODS:
Genomic DNA of the child was extracted and subjected to whole exome sequencing. Suspected variant was verified by Sanger sequencing of her family members.
RESULTS:
Cranial MRI suggested lobulated holoprosencephaly with partial absence of corpus callosum. Genetic testing revealed that she has carried a heterozygous c.517C>G (p.His173Asp) variant of the SIX3 gene, for which both of her parents were of wild type. Based on the American College of Medical Genetics and Genomics guidelines, the c.517C>G variant of SIX3 gene was predicted to be pathogenic (PS2+PM1+PM2+PM5+PP3).
CONCLUSION
The SIX3 gene c.517C>G variant probably underlay the multiple malformations in this child. Above finding has enabled her definite diagnosis.
Child
;
Family
;
Female
;
Heterozygote
;
Holoprosencephaly/genetics*
;
Humans
;
Mutation
;
Whole Exome Sequencing
4.Value of chromosomal microarray analysis for the diagnosis of fetuses with anomalies of central nervous system.
Peixuan CAO ; Xiangyu ZHU ; Leilei GU ; Wei LIU ; Jie LI
Chinese Journal of Medical Genetics 2023;40(2):181-185
OBJECTIVE:
To assess the value of chromosomal microarray analysis (CMA) for the diagnosis of fetuses with anomalies of the central nervous system (CNS) and summarize the outcome of the pregnancies and follow-up.
METHODS:
A total of 636 fetuses from June 2014 to December 2020 who were referred to the Prenatal Diagnosis Center of Nanjing Drum Tower Hospital due to abnormal CNS prompted by ultrasound were selected as the research subjects. Based on the ultrasound findings, the fetuses were divided into ventricular dilatation group (n = 441), choroid plexus cyst group (n = 41), enlarged posterior fossa group (n = 42), holoprosencephaly group (n = 15), corpus callosum hypoplasia group (n = 22), and other anomaly group (n = 75). Meanwhile, they were also divided into isolated (n = 504) and non-isolated (n = 132) groups based on the presence of additional abnormalities. Prenatal samples (amniotic fluid/chorionic villi/umbilical cord blood) or abortus tissue were collected for the extraction of genomic DNA and CMA assay. Outcome of the pregnancies and postnatal follow-up were summarized and subjected to statistical analysis.
RESULTS:
In total 636 fetuses with CNS anomalies (including 89 abortus tissues) were included, and 547 cases were followed up. The overall detection rate of CMA was 11.48% (73/636). The detection rates for the holoprosencephaly group, ACC group, choroid plexus cyst group, enlarged posterior fossa group, ventricular dilatation group and other anomaly group were 80% (12/15), 31.82% (7/22), 19.51% (8/41), 14.29% (6/42), 7.48% (33/441) and 9.33% (7/75), respectively. Compared with the isolated CNS anomaly group, the detection rate for the non-isolated CNS anomaly group was significantly higher (6.35% vs. 31.06%) (32/504 vs. 41/132) (χ² = 62.867, P < 0.001). Follow up showed that, for 52 fetuses with abnormal CMA results, 51 couples have opted induced labor, whilst 1 was delivered at full term with normal growth and development. Of the 434 fetuses with normal CMA results, 377 were delivered at full term (6 had developmental delay), and 57 couples had opted induced labor. The rate of adverse pregnancy outcome for non-isolated CNS abnormal fetuses was significantly higher than that of isolated CNS abnormal fetuses (26.56% vs. 10.54%) (17/64 vs. 39/370) (χ² = 12.463, P < 0.001).
CONCLUSION
Fetuses with CNS anomaly should be tested with CMA to determine the genetic cause. Most fetuses with negative CMA result have a good prognosis, but there is still a possibility for a abnormal neurological phenotype. Fetuses with CNS abnormalities in conjunct with other structural abnormalities are at increased risk for adverse pregnancy outcomes.
Female
;
Pregnancy
;
Humans
;
Holoprosencephaly
;
Prenatal Diagnosis/methods*
;
Central Nervous System
;
Fetus/abnormalities*
;
Nervous System Malformations/genetics*
;
Microarray Analysis
;
Central Nervous System Diseases
;
Cysts
;
Chromosome Aberrations
;
Ultrasonography, Prenatal/methods*
5.Clinical features and genetic analysis of a fetus with holoprosencephaly.
Jinzhe YU ; Chuang LI ; Yan ZHANG ; Jesse LI-LING ; Yuan LYU ; Hong CUI
Chinese Journal of Medical Genetics 2020;37(5):547-550
OBJECTIVE:
To analyze the clinical features and pathogenesis of a fetus with holoprosencephaly.
METHODS:
The findings of prenatal ultrasonography was reviewed. Following elective abortion, whole exome sequencing (WES) was carried out to identify potential pathogenic variant. Copy number variants (CNVs) of the abortus and its parents were detected by low-depth high-throughput sequencing. The parents were also analyzed by chromosomal karyotyping.
RESULTS:
Prenatal ultrasound suggested that the fetus had holoprosencephaly. WES revealed that it had approximately 33 Mb deletion at chromosome 13 involving ZIC2, a haploid dose sensitive gene. The results of low-depth high-throughput sequencing confirmed that the fetus carried a de novo 32.32 Mb deletion at 13q31.1-34. Karyotyping analysis has excluded gross chromosomal aberration in both parents.
CONCLUSION
The fetus was diagnosed with holoprosencephaly, which may be attributable to the 13q31.1-34 deletion involving the ZIC2 gene.
Adult
;
Chromosomes, Human, Pair 13
;
genetics
;
Female
;
Fetus
;
Genetic Testing
;
Holoprosencephaly
;
diagnostic imaging
;
genetics
;
pathology
;
Humans
;
Karyotyping
;
Male
;
Nuclear Proteins
;
genetics
;
Pregnancy
;
Prenatal Diagnosis
;
Sequence Deletion
;
Transcription Factors
;
genetics
;
Ultrasonography, Prenatal
;
Whole Exome Sequencing